132 related articles for article (PubMed ID: 35338328)
1. How effective is toluidine blue for screening and diagnosis of oral cancer and premalignant lesions?
Mills S
Evid Based Dent; 2022 Mar; 23(1):34-35. PubMed ID: 35338328
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of toluidine blue in the diagnosis and screening of oral cancer and pre-cancer: A systematic review and meta-analysis.
Kim DH; Song EA; Kim SW; Hwang SH
Clin Otolaryngol; 2021 Jan; 46(1):23-30. PubMed ID: 32741142
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of chemiluminescence in the diagnosis and screening of oral cancer and precancer: a systematic review and meta-analysis.
Kim DH; Lee J; Lee MH; Kim SW; Hwang SH
Braz J Otorhinolaryngol; 2022; 88(3):358-364. PubMed ID: 32847738
[TBL] [Abstract][Full Text] [Related]
4. Autofluorescence imaging to identify oral malignant or premalignant lesions: Systematic review and meta-analysis.
Kim DH; Kim SW; Hwang SH
Head Neck; 2020 Dec; 42(12):3735-3743. PubMed ID: 32866310
[TBL] [Abstract][Full Text] [Related]
5. A study to evaluate the efficacy of toluidine blue and cytology in detecting oral cancer and dysplastic lesions.
Rahman F; Tippu SR; Khandelwal S; Girish KL; Manjunath BC; Bhargava A
Quintessence Int; 2012 Jan; 43(1):51-9. PubMed ID: 22259809
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of non-invasive diagnostic methods in the diagnosis and screening of oral cancer and precancer.
Kim DH; Kim SW; Hwang SH
Braz J Otorhinolaryngol; 2022; 88(6):937-947. PubMed ID: 33642212
[TBL] [Abstract][Full Text] [Related]
7. Value of the ViziLite Plus System as a diagnostic aid in the early detection of oral cancer/premalignant epithelial lesions.
Mojsa I; Kaczmarzyk T; Zaleska M; Stypulkowska J; Zapala-Pospiech A; Sadecki D
J Craniofac Surg; 2012 Mar; 23(2):e162-4. PubMed ID: 22446458
[TBL] [Abstract][Full Text] [Related]
8. Comparing the efficacy of chemiluminescence with lugol's iodine versus toluidine blue in the diagnosis of dysplasia in tobacco associated oral lesions - A diagnostic study.
Swathi KV; Maragathavalli G; Uma Maheswari TN
Indian J Dent Res; 2021; 32(4):459-466. PubMed ID: 35645072
[TBL] [Abstract][Full Text] [Related]
9. Comparison of chemiluminescence and toluidine blue in the diagnosis of dysplasia in leukoplakia: a cross-sectional study.
Chaudhry A; Manjunath M; Ashwatappa D; Krishna S; Krishna AG
J Investig Clin Dent; 2016 May; 7(2):132-40. PubMed ID: 25532724
[TBL] [Abstract][Full Text] [Related]
10. The light at the end of the tunnel? Can light-based tests increase the accuracy of our diagnoses of pre-cancerous/cancerous lesions?
Coll Y; Geddes A; Thomson E
Evid Based Dent; 2022 Mar; 23(1):16-17. PubMed ID: 35338319
[TBL] [Abstract][Full Text] [Related]
11. Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: continuing research and implications for clinical practice.
Epstein JB; Sciubba J; Silverman S; Sroussi HY
Head Neck; 2007 Oct; 29(10):948-58. PubMed ID: 17764090
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of autofluorescence and toluidine blue in the differentiation of oral dysplastic and neoplastic lesions from non dysplastic and neoplastic lesions: a cross-sectional study.
Petruzzi M; Lucchese A; Nardi GM; Lauritano D; Favia G; Serpico R; Grassi FR
J Biomed Opt; 2014; 19(7):76003. PubMed ID: 24996662
[TBL] [Abstract][Full Text] [Related]
13. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue.
Epstein JB; Silverman S; Epstein JD; Lonky SA; Bride MA
Oral Oncol; 2008 Jun; 44(6):538-44. PubMed ID: 17996486
[TBL] [Abstract][Full Text] [Related]
14. Assessing the accuracy of autofluorescence, chemiluminescence and toluidine blue as diagnostic tools for oral potentially malignant disorders--a clinicopathological evaluation.
Awan KH; Morgan PR; Warnakulasuriya S
Clin Oral Investig; 2015 Dec; 19(9):2267-72. PubMed ID: 25804887
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic efficiency of toluidine blue with Lugol's iodine in oral premalignant and malignant lesions.
Nagaraju K; Prasad S; Ashok L
Indian J Dent Res; 2010; 21(2):218-23. PubMed ID: 20657091
[TBL] [Abstract][Full Text] [Related]
16. Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas.
Onofre MA; Sposto MR; Navarro CM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):535-40. PubMed ID: 11346731
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional saline infusion sonography compared to two-dimensional saline infusion sonography for the diagnosis of focal intracavitary lesions.
Nieuwenhuis LL; Hermans FJ; Bij de Vaate AJM; Leeflang MM; Brölmann HA; Hehenkamp WJ; Mol BWJ; Clark TJ; Huirne JA
Cochrane Database Syst Rev; 2017 May; 5(5):CD011126. PubMed ID: 28472862
[TBL] [Abstract][Full Text] [Related]
18. Increased allelic loss in toluidine blue-positive oral premalignant lesions.
Epstein JB; Zhang L; Poh C; Nakamura H; Berean K; Rosin M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):45-50. PubMed ID: 12539026
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive visual tools for diagnosis of oral cancer and dysplasia: A systematic review.
Giovannacci I; Vescovi P; Manfredi M; Meleti M
Med Oral Patol Oral Cir Bucal; 2016 May; 21(3):e305-15. PubMed ID: 26946204
[TBL] [Abstract][Full Text] [Related]
20. Inter-and intra-observer agreement on the judgment of toluidine blue staining for screening of oral potentially malignant disorders and oral cancer.
Li YN; Lu R; Zhang J; Zhou G
Clin Oral Investig; 2019 Apr; 23(4):1709-1714. PubMed ID: 30155573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
